Trials / Completed
CompletedNCT02227355
Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease
A Multi-center Noninterventional Study to Evaluate the Effectiveness of Neupro® (Rotigotine Transdermal Patch) and Levodopa Combination Therapy in Patients With Parkinson's Disease (NEUPART)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 195 (actual)
- Sponsor
- UCB Biopharma S.P.R.L. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the effectiveness of Rotigotine and Levodopa combination therapy for younger and older patients with Parkinson's Disease under real life conditions. Effects on ability to perform activities of daily living, sleep, medication dose and other factors will be assessed.
Conditions
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2014-08-28
- Last updated
- 2016-07-04
Locations
42 sites across 5 countries: France, Germany, Italy, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT02227355. Inclusion in this directory is not an endorsement.